The objectives of the study were to investigate the association between the severity of metabolic imbalances, insulin resistance, leptin levels, and the presence of cognitive disorders and to assess the possible protective roles of some classes of drugs used in the treatment of T2D and dyslipidemia in order to identify a viable target in the near future. Here, LEP is linked to cognitive disorder.